Vol 101, No 3 (2025)
- Year: 2025
- Published: 04.08.2025
- Articles: 9
- URL: https://vestnikdv.ru/jour/issue/view/116
- DOI: https://doi.org/10.25208/vdv.1013
Full Issue
HEALTH ORGANIZATION
Epidemiological and clinical aspects of syphilis incidence in the Russian Federation and the Republic of Tajikistan: comparative analysis
Abstract
The paper discusses the epidemiological and clinical aspects of syphilis in the Russian Federation and the Republic of Tajikistan, as well as the main key trends and challenges associated with this infection. In 2021 and 2022, after a long period of decline, there was a significant rise in the incidence of syphilis in Russia, with a 69.7 % increase compared to 2020. Increased incidence in 2021–2022 was largely due to the increased incidence among foreign citizens: 2,801 in 2020, 7,710 in 2021, and 12,748 in 2022. In 2023, 10,160 cases of syphilis were detected among foreign citizens in Russia, of which 1,875 (18.5%) were from Tajikistan, whereas only 368 cases were reported in Tajikistan. In Russia, the proportion of advanced and unspecified syphilis increased from 2015 to 2023 due to increased incidence among foreign citizens. Since 2019, advanced forms of syphilis that were previously undetected have also been reported in the Republic of Tajikistan. The effective work of dermatovenereological services in the Russian Federation and the Republic of Tajikistan has contributed to a significant decrease in the incidence of syphilis among children and adolescents. In Russia, the incidence rate among children aged 0 to 14 decreased from 228 cases in 2015 to 34 in 2023, and among adolescents aged 15 to 17, it decreased from 391 to 159 cases. No syphilis cases in these age groups have not been reported in Tajikistan. The number of cases of congenital syphilis in Russia decreased from 63 to 12, while in Tajikistan this value varied from 0 to 5 cases. The article highlights the differences in the algorithms for diagnosing syphilis in specific target populations and in advanced forms of the disease, which can lead to undiagnosed cases of the disease.



REVIEWS
Angiogenesis in mycosis fungoides: pathogenetic significance and therapeutic options
Abstract
Mycosis fungoides is a primary epidermotropic cutaneous T-cell lymphoma characterized by proliferation of small and medium-sized T-lymphocytes with cerebriform nuclei. The pathogenesis of this disease is complex and has not been completely investigated, but angiogenesis plays a significant role. Angiogenesis is the process of forming new blood vessels based on an existing vascular network, which includes extracellular matrix remodeling, endothelial cell migration and proliferation, capillary bed cell differentiation, and formation of anastomoses. In case of mycosis fungoides, the best investigated markers of angiogenesis include CD31, CD34, angiogenin, angiopoietin-1, angiopoietin-2, VEGF-A, VEGF-C, PlGF, MMP-2, and MMP-9. The current data on the pathogenetic aspects of angiogenesis in patients with mycosis fungoides are encouraging, however the small and heterogeneous patient populations and the limited number of the pro- and anti-angiogenic factors investigated necessitate further researches. Angiogenesis markers can be considered as potential additional differential diagnostic criteria, prognostic signs, and therapeutic targets in patients with mycosis fungoides.



ORIGINAL STUDIES
Narrow-band mid-wave uгltraviolet therapy in patients with mycosis fungoides
Abstract
Background. Standardization of the approach to the prescription of UVB-311 in mycosis fungoides is an urgent problem that requires prospective studies aimed at finding the most effective and safe treatment regimens.
Aim. To assess the efficacy of an optimized regimen of narrow-band medium-wave ultraviolet therapy in the treatment of patients with mycosis fungoides compared to PUVA therapy.
Methods. The authors performed a prospective non-randomized comparative study. The study enrolled 30 patients with early-stage mycosis fungoides (IA–IIA): 15 patients received UVB-311, 15 received PUVA therapy with oral administration of the photosensitizer Ammi majoris fructuum furocumarini. Therapeutic efficacy was assessed at the 10th, 20th, and final treatment sessions using the mSWAT and BSA criteria.
Results. A comparative analysis of therapeutic efficacy showed no statistically significant differences in changes in BSA and mSWAT clinical indices between UVB-311 and PUVA therapy (p > 0.05). The proportion of total response (the sum of complete and partial remission) did not differ between the treatment groups, it constituted 93.3% (n = 14).
Conclusion. In the proposed regimen, UVB-311 is comparable to PUVA in patients with early-stage mycosis fungoides.



Unification of dermatoscopic terminology in the russian language
Abstract
Background. Today, two main approaches to interpreting dermatoscopic images are used: descriptive and metaphorical terminology. The lack of a unified dermatoscopic terminology in the Russian language brings risks of ambiguous interpretation of signs, difficulties in describing dermatoscopic status, challenges in follow-up monitoring, and limited comparability of scientific data.
Aim. To assess the terminology and protocols used in dermatoscopy when providing medical care to patients with cutaneous and subcutaneous diseases, skin neoplasms, and cosmetic skin defects in order to improve the quality of medical care.
Methods. A special questionnaire (52 questions) was developed. Interviews may be performed in a mixed format. An anonymous survey of 402 physicians was conducted. Respondents were asked to describe three dermatoscopic images.
Results. The vast majority of respondents noted the following aspects: the need for specialized terminology in order to describe and understand the dermatoscopic status (95%); lack of previously acquired knowledge and skills to use this diagnostic method freely (73.4%); and need for in-depth investigation of terminological nuances (89.1%). Most respondents (93.5%) supported the idea of establishing a unified dermatoscopic terminology in Russian. The specialists concerned use an extremely wide range of terms to describe the dermatoscopic presentation. More than a half of the respondents (58.5 %) reported difficulties in interpreting the dermatoscopic presentation of skin neoplasms described by another specialist.
Conclusion. The analysis revealed no unified standards for dermatoscopic terminology in Russian. The development of a standardized terminological system for dermatoscopy in the Russian Federation requires consensus conferences involving the specialists concerned, elaboration of proposed advanced training programs on dermatoscopy as well as relevant methodological recommendations, and their consistent implementation in advanced training programs for doctors of various specialties (within medical universities and postgraduate education system).



Medical care for pemphigus patients in medical institutions specializing in dermatovenereology
Abstract
Background. Proper medical care for pemphigus patients using the necessary diagnostic and therapeutic methods can prevent severe disease progression and death.
Aim. To analyze diagnostic and therapeutic approaches for pemphigus in medical institutions specializing in dermatovenereology and assess their compliance with clinical guidelines.
Methods. A questionnaire was developed to collect data on the number of pemphigus patients treated in medical institutions specializing in dermatovenereology across the federal subjects of the Russian Federation in 2023 and on the diagnostic and therapeutic methods employed.
Results. Sixty eight medical institutions specializing in dermatovenereology in 66 (74.2%) federal subjects of the Russian Federation (RF) provided data on 1,480 pemphigus patients. Their diagnostic approaches (based on their own or other facilities) comprised: cytological examination of the smear print from the base of erosions (66 federal subjects); histopathological analysis of skin biopsies (46 federal subjects; 69.7%); ELISA blood test for anti-desmoglein type 1 and/or 3 autoantibodies level (29 federal subjects; 43.9%); immunofluorescence testing of skin biopsies (16 federal subjects; 24.2%), serological diagnostics by indirect immunofluorescence using monkey esophagus substrate to determine anti-desmoglein type 1 and/or 3 autoantibodies in blood (11 federal subjects; 16.7%). Systemic glucocorticoids were used to treat patients with pemphigus in 66 (100.0%) federal subjects of RF, though the medical institutions from 21 federal subjects (31.8%) restricted therapy to parenteral corticosteroids only.
Conclusion. The conducted study identified quality issues in specialized pemphigus care and suboptimal adherence to clinical guidelines.



GUIDELINES FOR PRACTITIONERS
Desmoplastic melanoma of the skin: current aspects of morphological and immunohistochemical diagnosis
Abstract
To study the clinical, morphological, and immunohistochemical characteristics of desmoplastic melanoma and the use of modern diagnostic technologies to refine the classification criteria for this rare subtype of malignant neoplasms. The study included 5 patients (4 men and 1 woman, median age 62.5 years) diagnosed with malignant neoplasms of the skin on the back (3 cases) and the buccal area of the face (2 cases). Morphological and immunohistochemical studies were performed using markers S100 and Melan-A to confirm the diagnosis. Modern technologies were applied to improve diagnostic accuracy. Morphological analysis revealed the characteristic dense collagenized stroma and low cellular density of desmoplastic melanoma tumors. Immunohistochemical analysis confirmed the melanocytic origin of the tumors. The use of modern diagnostic methods allows us to determine diagnostic and classification criteria for desmoplastic melanoma. A comprehensive approach, including morphological and immunohistochemical methods with markers S100 and Melan-A, enhances diagnostic accuracy and refines the classification criteria for this disease.



Successful experience of secukinumab therapy in a patient with severe chronic suppurative hidradenitis
Abstract
Severe forms of suppurative hidradenitis are characterized by a chronic recurrent course, accompanied by active inflammation, formation of nodes and abscesses, fistulous tracts with abundant purulent discharge and scarring. The case narrative concerns a patient who was not diagnosed with chronic suppurative hidradenitis for a long time. Misdiagnoses included “acne inversa”, “chronic furunculosis”, “chronic pyoderma”, and “secondary immunodeficiency”. The patient received short courses of antibacterial drugs, isotretinoin, systemic glucocorticosteroids, and ineffective surgical treatment. The lack of a correct diagnosis, inappropriate management strategy, and ineffective therapy over several years resulted in disease progression and patient’s disability and incapacity. The diagnosis of chronic purulent hidradenitis and administration of secukinumab yielded positive outcomes. Twelve months of secukinumab treatment resulted in sustained remission. The case narrative concerning the patient with severe suppurative hidradenitis showed that the treatment can be effective and that the drug is tolerated well.



CLINICAL CASE REPORTS
Manifestation of basal cell carcinoma in a 10-year-old child
Abstract
Basal cell carcinoma is one of the most common types of skin cancer among adults, but in children it is extremely rare and is usually associated with genetic syndromes (for example, Gorlin–Goltz syndrome or xeroderma pigmentosum) or with the consequences of radiation therapy performed in children. We present a clinical case of a 10-year-old child diagnosed with basal cell carcinoma. The child’s parents consented to the publication of the data. A 10-year-old patient, accompanied by his mother, came to the outpatient department of the St. Petersburg Clinical Scientific and Practical Center for Specialized Types of Medical Care (Oncology) named after N.P. Napalkov (KNPC SVMP) with complaints about a formation that was detected 4 months ago and was increasing in size. From the family history it is known that the boy’s mother was diagnosed with Hodgkin’s lymphoma at the age of 13, for which chemoradiotherapy was performed. At the age of 30, she was diagnosed with multiple basal cell carcinomas in the area of radiation.



Experience with secukinumab treatment in a patient with severe psoriasis associated with HIV infection
Abstract
Psoriasis is a chronic, immune-mediated, genetic disorder characterized by skin lesions and musculoskeletal system injuries and affected by external and internal factors. Currently, one of the primary challenges in modern dermatovenereology is managing patients with chronic dermatoses including moderate-to-severe psoriasis. This article presents a case narrative concerning the use of secukinumab, an IL-17A inhibitor, in an HIV-positive patient with severe psoriasis and psoriatic arthritis. The disease course was characterized by significant cutaneous and articular syndromes along with resistance to disease modifying anti-rheumatic therapy. Secukinumab treatment of this patient helped to improve both dermatological and musculoskeletal symptoms. The safety and high efficacy of secukinumab enable complete disease control and improve the quality of life in patients with moderate-to-severe plaque psoriasis emphasizing the need for the use of genetically engineered biological drugs.


